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THE  IMPACT OF CEREBRAL INJURY IN  DONATION AND TRANSPLANTATION 




Organ transplantation is a life saving therapy for patients with end stage organ 
failure. In general, patients who received a solid organ transplant live longer and 
have a better quality of life compared to those on organ replacement therapies. 
Nowadays, due to improved organ preservation methods, better surgical 
techniques, new immunosuppressant drugs and regimens, severe rejection is less 
frequent. Because of these major achievements, the number of patients eligible for 
transplantation has increased. Despite the inclusion of patients with more co-
morbidities, over the last years transplant survival has stabilised. The worldwide 
increasing demand for organs forced a gradual shift towards accepting suboptimal 
donor organs from for instance older brain dead donors and even donation after 
cardiac death donors. The aim of this thesis was to study the role of the intestine in 
brain death induced injury. Both experimental and clinical studies were focussed on 
inflammation in relationship with intestinal permeability.  
In chapter 1, the background leading to the hypothesis that intestinal inflammation 
leads to enhanced intestinal permeability, which causes bacterial translocation, 
provoking cytokine release, is explained. This chapter concludes with the aims of 
this thesis. The effects of brain death on the donor intestine in an experimental rat 
model were studied in chapter 2. Brain death was induced by inflation of a 
subdural placed balloon catheter. We observed that intestinal inflammation and 
apoptosis occurred early after brain death induction, characterized by an increased 
polymorphonuclear cell influx in the intestine, intercellular adhesion molecule-1, 
vascular cell adhesion molecule-1, E-Selectin, and interleukin-6. Caspase-3 
positive cells were found in jejunum and ileum in the brain dead rats. These events 
may ultimately have a negative influence on the outcome of intestinal 
transplantation. In chapter 3, we hypothesised that increased intestinal 
permeability occurs during brain death. Therefore changes in intestinal barrier 
function were investigated, in a similar animal model as described in chapter 2. In 
the serum of brain dead rats we found higher lipopolysaccharide and 
lipopolysaccharide binding protein levels, indicative of endotoxemia. The 
lipopolysaccharide binding protein (LBP) mRNA expression was significantly 
increased in liver and intestine in the brain dead rats. The results support the 
hypothesis that brain death induced intestinal inflammation leads to enhanced 
intestinal permeability, which causes bacterial translocation, provoking cytokine 
release. This vicious circle may contribute to the inflammatory reaction in potential 
donor organs which results in distant organ failure and inferior transplant outcome. 
The first clinical study of this thesis (chapter 4) describes whether the inflammatory 
response present in deceased brain dead donors could be explained by the 
leakage of pro-inflammatory proteins from the injured brain into the circulation. In 
deceased brain dead donors, glial fibrillary acidic protein (GFAP) as a marker of 
blood-brain barrier dysfunction, and interleukin-6 as a key pro-inflammatory 
cytokine were measured, at the beginning and the end of the brain death period. 
Our results show increased levels of GFAP in DBD donors at the declaration of 
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brain death compared to living donors. During the brain death period, GFAP levels 
were markedly elevated in the majority of deceased brain dead donors, indicating a 
distinct dysfunction of the blood-brain barrier. In chapter 5, we studied serum 
vascular endothelial growth factor (VEGF), angiopoietin-1 and angiopoietin-2 in 
deceased brain dead donors using living kidney donors as controls. We postulated 
that the anti-inflammatory angiopoietin-1 and the pro-inflammatory angiopoietin-2 is 
modulated progressively towards inflammation during the period of brain death 
prior to organ recovery. Deceased brain dead donors had higher median serum 
LBP, VEGF and angiopoietin-2 levels compared to living donors. Higher 
angiopoietin-1 levels were observed just after brain death diagnosis. Importantly, 
serum angiopoietin-2 levels in the deceased brain dead donor predicted the 
chance on rejection in the first year after kidney transplantation. We studied the 
potential of angiopoietin-2 in donor serum as a biomarker for transplant outcome 
(chapter 6). Donor-derived biomarkers that have predictive value for post 
transplant outcome are useful to prevent unnecessary discard of donor organs and 
to fine-tune post-operative treatment of the recipient. We show that angiopoietin-2 
measured in donor serum prior to donation is an independent predictor of kidney 
graft survival. From 297 deceased kidney donors included in an international 
prospective randomized controlled trial, serum was analyzed for angiopoietin-1 and 
angiopoietin-2. Using multivariate models, we tested whether donor serum 
angiopoietins were independently associated with delayed graft function, primary 
non-function and graft survival. Serum angiopoietin-2 concentration was 
significantly associated with graft survival: higher values in donor serum were 
predictive of a lower risk of graft failure. 
Perspectives 
The first question in this thesis was if brain death itself had an effect on the 
intestine, similar to the kidney, the liver and the lung. In chapter 2, we described 
inflammation and apoptosis in an experimental brain death model in the rat. In 
chapter 3, we extended these findings and described an enhanced permeability in 
brain dead rats.  
The exact pathogenesis of intestinal damage however remains to be established. 
Future research should therefore focus on the role of the intestine in systemic 
inflammation. Because of the unique structure of the intestine, and its importance 
in the lymphatic system, experimental studies could focus on the role of mesenteric 
lymph in the cascade of brain death induces injury. With cannulation of the 
mesenteric lymph vessel, the cytotoxity of lymph from brain dead rats could be 
assessed. At the same time, this experimental model gives insight in the 
contribution of mesenteric lymph flow in the inflammatory cascade to distant 
organs, such as heart, lung, liver and kidney. For example in burn induced lung 
injury, mesenteric lymph flow does significantly contribute to inflammation in the 
lung. If obstruction of the mesenteric lymph flow does prevent the inflammatory 
cascade to the distant organs, this could be implemented in the clinical situation. 
Therapies, such as adequate enteral feeding, or medication such as 2-
Mercaptopropionylglycine which enhance the intestinal integrity could be applied. 
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Also substances, such as LBP, which capture hazardous lipopolysaccharide could 
have a beneficial effect on the pro-inflammatory state in de deceased donor and 
subsequent graft quality. 
The second important observation in this thesis is that the anti-inflammatory protein 
angiopoietin-1 and the pro-inflammatory angiopoietin-2 are modulated 
progressively towards inflammation during the period of brain death prior to organ 
recovery (chapter 5). Moreover, donor serum angiopoietin-2 has the potential to 
independently predict transplant outcome in the recipient (chapter 6). To confirm 
the clinical validity of serum angiopoietin-2, these measurements should be 
repeated in another cohort of donors. Also the potential of angiopoietin-1 and 
angiopoietin-2 to predict outcome in other transplants such as the liver, lung, heart, 
pancreas and intestine should be investigated. Before implementing angiopoietin-2 
in the clinical setting, a fast, easy, and validated test must be developed. 
Furthermore, also after transplantation, angiopoietins in the recipient could have an 
additive effect on outcome. Also intervening in the angiopoietin-1 vs. angiopoietin-2 
balance could therefore be a target to improve organ quality, both prior and after 
donation.
